3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues

Area of Science:

• Medicinal Chemistry
• Computational Drug Design
• Oncology

Background:

• Prostate cancer is a leading cause of cancer death in men, with limited treatment options for metastatic disease.
• Curcumin, a natural compound, demonstrates inhibitory effects on prostate cancer cell proliferation.
• Androgen-independent prostate cancer presents a significant therapeutic challenge.

Purpose of the Study:

• To design novel curcumin analogs with enhanced anti-prostate cancer activity.
• To reduce toxicity and side effects associated with existing treatments.
• To develop more effective therapeutic agents for prostate cancer.

Main Methods:

• Utilized three-dimensional quantitative structure-activity relationship (3DQSAR) studies on 34 curcumin analogs.
• Performed molecular docking studies targeting the 3ZK6 protein.
• Employed OSIRIS Property Explorer for predicting drug-related properties of novel compounds.

Main Results:

• The optimal CoMSIA model achieved high statistical significance (q2=0.540, R2=0.984, Rext2=0.792).
• CoMSIA contour maps provided insights into structure-activity relationships.
• Molecular docking revealed significant interactions between active compounds and amino acids of the 3ZK6 protein target.

Conclusions:

• Compound 28i emerged as a promising candidate for a new anti-prostate cancer drug.
• The designed analogs exhibit potentially higher biological activity.
• Further development of compound 28i is warranted for its therapeutic potential.